Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 455 entries
Sorted by: Best Match Show Resources per page
Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD.

Iranian journal of reproductive medicine

Ramazanzadeh F, Tavakolianfar T, Shariat M, Purafzali Firuzabadi SJ, Hagholahi F.
PMID: 25242973
Iran J Reprod Med. 2012 Jan;10(1):41-6.

BACKGROUND: The levonorgestrel-releasing IUD can help the treatment of dysmenorrhea by reducing the synthesis of endometrial prostaglandins as a conventional treatment.OBJECTIVE: This study was performed to assess the frequency of dysmenorrhea, satisfaction and quality of life in women using...

Cite
Ramazanzadeh F, Tavakolianfar T, Shariat M, et al. Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD. Iran J Reprod Med. 2012;10(1):41-6
Ramazanzadeh, F., Tavakolianfar, T., Shariat, M., Purafzali Firuzabadi, S. J., & Hagholahi, F. (2012). Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD. Iranian journal of reproductive medicine, 10(1), 41-6.
Ramazanzadeh, Fatemeh, et al. "Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD." Iranian journal of reproductive medicine vol. 10,1 (2012): 41-6.
Ramazanzadeh F, Tavakolianfar T, Shariat M, Purafzali Firuzabadi SJ, Hagholahi F. Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD. Iran J Reprod Med. 2012 Jan;10(1):41-6. PMID: 25242973; PMCID: PMC4163262.
Copy Download .nbib Format: NLM
Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety.

International journal of women's health

Leminen H, Hurskainen R.
PMID: 22956886
Int J Womens Health. 2012;4:413-21. doi: 10.2147/IJWH.S13840. Epub 2012 Aug 17.

Tranexamic acid has proven to be an effective treatment for heavy menstrual bleeding (HMB). It reduces menstrual blood loss (MBL) by 26%-60% and is significantly more effective than placebo, nonsteroidal anti-inflammatory drugs, oral cyclical luteal phase progestins, or oral...

Cite
Leminen H, Hurskainen R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012;4:413-21doi: 10.2147/IJWH.S13840.
Leminen, H., & Hurskainen, R. (2012). Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. International journal of women's health, 4413-21. https://doi.org/10.2147/IJWH.S13840
Leminen, Henri, and Hurskainen, Ritva. "Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety." International journal of women's health vol. 4 (2012): 413-21. doi: https://doi.org/10.2147/IJWH.S13840
Leminen H, Hurskainen R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012;4:413-21. doi: 10.2147/IJWH.S13840. Epub 2012 Aug 17. PMID: 22956886; PMCID: PMC3430088.
Copy Download .nbib Format: NLM
Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016.

Drugs - real world outcomes

Azekour K, Belamalem S, Soulaymani A, El Houate B, El Bouhali B.
PMID: 30820765
Drugs Real World Outcomes. 2019 Mar;6(1):11-17. doi: 10.1007/s40801-019-0148-2.

BACKGROUND: Drug overdose, either accidental or intentional, is the most common cause of acute poisoning worldwide.OBJECTIVE: The aim of this study was to determine the epidemiological profile of drug poisoning recorded in the south east of Morocco and to...

Cite
Azekour K, Belamalem S, Soulaymani A, et al. Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016. Drugs Real World Outcomes. 2019;6(1):11-17doi: 10.1007/s40801-019-0148-2.
Azekour, K., Belamalem, S., Soulaymani, A., El Houate, B., & El Bouhali, B. (2019). Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016. Drugs - real world outcomes, 6(1), 11-17. https://doi.org/10.1007/s40801-019-0148-2
Azekour, Karima, et al. "Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016." Drugs - real world outcomes vol. 6,1 (2019): 11-17. doi: https://doi.org/10.1007/s40801-019-0148-2
Azekour K, Belamalem S, Soulaymani A, El Houate B, El Bouhali B. Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016. Drugs Real World Outcomes. 2019 Mar;6(1):11-17. doi: 10.1007/s40801-019-0148-2. PMID: 30820765; PMCID: PMC6423242.
Copy Download .nbib Format: NLM
Assessment of a high-fidelity mobile simulator for intrauterine contraception training in ambulatory reproductive health centres.

Journal of European CME

Dodge LE, Hacker MR, Averbach SH, Voit SF, Paul ME.
PMID: 29644120
J Eur CME. 2016 Feb 12;5(1):30416. doi: 10.3402/jecme.v5.30416. eCollection 2016.

OBJECTIVES: Little is known about the utility of simulation-based training in office gynaecology. The objective of this cross-sectional study was to evaluate the self-reported effectiveness and acceptability of the PelvicSim™ (VirtaMed), a high-fidelity mobile simulator, to train clinicians in...

Cite
Dodge LE, Hacker MR, Averbach SH, et al. Assessment of a high-fidelity mobile simulator for intrauterine contraception training in ambulatory reproductive health centres. J Eur CME. 2016;5(1):30416doi: 10.3402/jecme.v5.30416.
Dodge, L. E., Hacker, M. R., Averbach, S. H., Voit, S. F., & Paul, M. E. (2016). Assessment of a high-fidelity mobile simulator for intrauterine contraception training in ambulatory reproductive health centres. Journal of European CME, 5(1), 30416. https://doi.org/10.3402/jecme.v5.30416
Dodge, Laura E, et al. "Assessment of a high-fidelity mobile simulator for intrauterine contraception training in ambulatory reproductive health centres." Journal of European CME vol. 5,1 (2016): 30416. doi: https://doi.org/10.3402/jecme.v5.30416
Dodge LE, Hacker MR, Averbach SH, Voit SF, Paul ME. Assessment of a high-fidelity mobile simulator for intrauterine contraception training in ambulatory reproductive health centres. J Eur CME. 2016 Feb 12;5(1):30416. doi: 10.3402/jecme.v5.30416. eCollection 2016. PMID: 29644120; PMCID: PMC5843069.
Copy Download .nbib Format: NLM
Recurrent atypical polypoid adenomyoma and pregnancy: A new conservative approach with levonorgestrel-releasing intrauterine system.

Gynecologic oncology reports

Solima E, Liprandi V, Belloni GM, Vignali M, Busacca M.
PMID: 28761925
Gynecol Oncol Rep. 2017 Jul 12;21:84-85. doi: 10.1016/j.gore.2017.07.002. eCollection 2017 Aug.

•Levonorgestrel IUD was effective in treatment of recurrent APA.•No side effects were reported.•No impairments on a subsequent pregnancy were reported.

Cite
Solima E, Liprandi V, Belloni GM, et al. Recurrent atypical polypoid adenomyoma and pregnancy: A new conservative approach with levonorgestrel-releasing intrauterine system. Gynecol Oncol Rep. 2017;21:84-85doi: 10.1016/j.gore.2017.07.002.
Solima, E., Liprandi, V., Belloni, G. M., Vignali, M., & Busacca, M. (2017). Recurrent atypical polypoid adenomyoma and pregnancy: A new conservative approach with levonorgestrel-releasing intrauterine system. Gynecologic oncology reports, 2184-85. https://doi.org/10.1016/j.gore.2017.07.002
Solima, Eugenio, et al. "Recurrent atypical polypoid adenomyoma and pregnancy: A new conservative approach with levonorgestrel-releasing intrauterine system." Gynecologic oncology reports vol. 21 (2017): 84-85. doi: https://doi.org/10.1016/j.gore.2017.07.002
Solima E, Liprandi V, Belloni GM, Vignali M, Busacca M. Recurrent atypical polypoid adenomyoma and pregnancy: A new conservative approach with levonorgestrel-releasing intrauterine system. Gynecol Oncol Rep. 2017 Jul 12;21:84-85. doi: 10.1016/j.gore.2017.07.002. eCollection 2017 Aug. PMID: 28761925; PMCID: PMC5524299.
Copy Download .nbib Format: NLM
RE: "An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device".

Neuro-ophthalmology (Aeolus Press)

Golozar A, Schoendorf J.
PMID: 30723528
Neuroophthalmology. 2018 Jul 27;43(1):67-69. doi: 10.1080/01658107.2018.1465439. eCollection 2019 Feb.

The current letter to the editor describes some of the limitations of Valenzuela et al.'s study on the association between levonorgestrel-releasing intrauterine system use and pseudotumor cerebri/idiopathic intracranial hypertension and further reinforces the authors' interpretations of the findings.

Cite
Golozar A, Schoendorf J. RE: "An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device". Neuroophthalmology. 2018;43(1):67-69doi: 10.1080/01658107.2018.1465439.
Golozar, A., & Schoendorf, J. (2019). RE: "An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device". Neuro-ophthalmology (Aeolus Press), 43(1), 67-69. https://doi.org/10.1080/01658107.2018.1465439
Golozar, Asieh, and Schoendorf, Juliane. "RE: "An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device"." Neuro-ophthalmology (Aeolus Press) vol. 43,1 (2019): 67-69. doi: https://doi.org/10.1080/01658107.2018.1465439
Golozar A, Schoendorf J. RE: "An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device". Neuroophthalmology. 2018 Jul 27;43(1):67-69. doi: 10.1080/01658107.2018.1465439. eCollection 2019 Feb. PMID: 30723528; PMCID: PMC6351020.
Copy Download .nbib Format: NLM
State of emergency contraception in the U.S., 2018.

Contraception and reproductive medicine

Haeger KO, Lamme J, Cleland K.
PMID: 30202545
Contracept Reprod Med. 2018 Sep 05;3:20. doi: 10.1186/s40834-018-0067-8. eCollection 2018.

Emergency contraception is indicated in instances of unprotected sexual intercourse, including reproductive coercion, sexual assault, and contraceptive failure. It plays a role in averting unintended pregnancies due to inconsistent use or non-use of contraception. Options for emergency contraception vary...

Cite
Haeger KO, Lamme J, Cleland K. State of emergency contraception in the U.S., 2018. Contracept Reprod Med. 2018;3:20doi: 10.1186/s40834-018-0067-8.
Haeger, K. O., Lamme, J., & Cleland, K. (2018). State of emergency contraception in the U.S., 2018. Contraception and reproductive medicine, 320. https://doi.org/10.1186/s40834-018-0067-8
Haeger, Kristin O, et al. "State of emergency contraception in the U.S., 2018." Contraception and reproductive medicine vol. 3 (2018): 20. doi: https://doi.org/10.1186/s40834-018-0067-8
Haeger KO, Lamme J, Cleland K. State of emergency contraception in the U.S., 2018. Contracept Reprod Med. 2018 Sep 05;3:20. doi: 10.1186/s40834-018-0067-8. eCollection 2018. PMID: 30202545; PMCID: PMC6123910.
Copy Download .nbib Format: NLM
Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management.

Healthcare (Basel, Switzerland)

Nwanodi O.
PMID: 28698465
Healthcare (Basel). 2017 Jul 08;5(3). doi: 10.3390/healthcare5030030.

Globally, endometrial cancer is the sixth leading cause of female cancer-related deaths. Non-atypical endometrial hyperplasia (EH), has a lifetime progression rate to endometrial cancer ranging from less than 5%, if simple without atypia, to 40%, if complex with atypia....

Cite
Nwanodi O. Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management. Healthcare (Basel). 2017;5(3)doi: 10.3390/healthcare5030030.
Nwanodi, O. (2017). Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management. Healthcare (Basel, Switzerland), 5(3), . https://doi.org/10.3390/healthcare5030030
Nwanodi, Oroma. "Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management." Healthcare (Basel, Switzerland) vol. 5,3 (2017). doi: https://doi.org/10.3390/healthcare5030030
Nwanodi O. Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management. Healthcare (Basel). 2017 Jul 08;5(3). doi: 10.3390/healthcare5030030. PMID: 28698465; PMCID: PMC5618158.
Copy Download .nbib Format: NLM
Lower hormone dosage with improved cycle control.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

Vree M.
PMID: 29243956
Eur J Contracept Reprod Health Care. 2002 Dec;7:25-30. doi: 10.1080/13625187.2002.11949332.

Cycle control is a key factor that influences contraceptive acceptability and compliance. In combined oral contraceptives (COC), reducing the daily dose of ethinylestradiol (EE) can compromise cycle control. As NuvaRing, the novel combined contraceptive vaginal ring, releases only 15...

Cite
Vree M. Lower hormone dosage with improved cycle control. Eur J Contracept Reprod Health Care. 2002;7:25-30doi: 10.1080/13625187.2002.11949332.
Vree, M. (2002). Lower hormone dosage with improved cycle control. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 725-30. https://doi.org/10.1080/13625187.2002.11949332
Vree, M. "Lower hormone dosage with improved cycle control." The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception vol. 7 (2002): 25-30. doi: https://doi.org/10.1080/13625187.2002.11949332
Vree M. Lower hormone dosage with improved cycle control. Eur J Contracept Reprod Health Care. 2002 Dec;7:25-30. doi: 10.1080/13625187.2002.11949332. PMID: 29243956.
Copy Download .nbib Format: NLM
High-sensitivity simultaneous liquid chromatography-tandem mass spectrometry assay of ethinyl estradiol and levonorgestrel in human plasma.

Journal of pharmaceutical analysis

Gandhi A, Guttikar S, Trivedi P.
PMID: 29403945
J Pharm Anal. 2015 Oct;5(5):316-326. doi: 10.1016/j.jpha.2015.02.002. Epub 2015 Feb 20.

A sensitive and simultaneous liquid chromatography-tandem mass spectrometry method was developed and validated for quantification of ethinyl estradiol and levonorgestrel. The analytes were extracted with methyl-tert-butyl ether: n-hexane (50:50, v/v) solvent mixture, followed by dansyl derivatization. The chromatographic separation...

Cite
Gandhi A, Guttikar S, Trivedi P. High-sensitivity simultaneous liquid chromatography-tandem mass spectrometry assay of ethinyl estradiol and levonorgestrel in human plasma. J Pharm Anal. 2015;5(5):316-326doi: 10.1016/j.jpha.2015.02.002.
Gandhi, A., Guttikar, S., & Trivedi, P. (2015). High-sensitivity simultaneous liquid chromatography-tandem mass spectrometry assay of ethinyl estradiol and levonorgestrel in human plasma. Journal of pharmaceutical analysis, 5(5), 316-326. https://doi.org/10.1016/j.jpha.2015.02.002
Gandhi, Abhishek, et al. "High-sensitivity simultaneous liquid chromatography-tandem mass spectrometry assay of ethinyl estradiol and levonorgestrel in human plasma." Journal of pharmaceutical analysis vol. 5,5 (2015): 316-326. doi: https://doi.org/10.1016/j.jpha.2015.02.002
Gandhi A, Guttikar S, Trivedi P. High-sensitivity simultaneous liquid chromatography-tandem mass spectrometry assay of ethinyl estradiol and levonorgestrel in human plasma. J Pharm Anal. 2015 Oct;5(5):316-326. doi: 10.1016/j.jpha.2015.02.002. Epub 2015 Feb 20. PMID: 29403945; PMCID: PMC5762240.
Copy Download .nbib Format: NLM
Task shifting levonorgestrel implant insertion to community midwife assistants in Malawi: results from a non-inferiority evaluation.

Contraception and reproductive medicine

Davis DN, Lemani C, Kamtuwanje N, Phiri B, Masepuka P, Kuchawo S, Bhushan NL, Tang JH.
PMID: 30410788
Contracept Reprod Med. 2018 Nov 01;3:24. doi: 10.1186/s40834-018-0077-6. eCollection 2018.

BACKGROUND: In 2013, Malawi began task shifting long acting reversible contraception (LARC) insertion from Nurse Midwife Technicians (NMTs), who undergo 3 years of training, to Community Midwife Assistants (CMAs), who undergo 18 months of training. However, there is no...

Cite
Davis DN, Lemani C, Kamtuwanje N, et al. Task shifting levonorgestrel implant insertion to community midwife assistants in Malawi: results from a non-inferiority evaluation. Contracept Reprod Med. 2018;3:24doi: 10.1186/s40834-018-0077-6.
Davis, D. N., Lemani, C., Kamtuwanje, N., Phiri, B., Masepuka, P., Kuchawo, S., Bhushan, N. L., & Tang, J. H. (2018). Task shifting levonorgestrel implant insertion to community midwife assistants in Malawi: results from a non-inferiority evaluation. Contraception and reproductive medicine, 324. https://doi.org/10.1186/s40834-018-0077-6
Davis, Dylane N, et al. "Task shifting levonorgestrel implant insertion to community midwife assistants in Malawi: results from a non-inferiority evaluation." Contraception and reproductive medicine vol. 3 (2018): 24. doi: https://doi.org/10.1186/s40834-018-0077-6
Davis DN, Lemani C, Kamtuwanje N, Phiri B, Masepuka P, Kuchawo S, Bhushan NL, Tang JH. Task shifting levonorgestrel implant insertion to community midwife assistants in Malawi: results from a non-inferiority evaluation. Contracept Reprod Med. 2018 Nov 01;3:24. doi: 10.1186/s40834-018-0077-6. eCollection 2018. PMID: 30410788; PMCID: PMC6211513.
Copy Download .nbib Format: NLM
Quick starting hormonal contraception after using oral emergency contraception: a systematic review.

The journal of family planning and reproductive health care

Murphy LE, Chen ZE, Warner V, Cameron ST.
PMID: 28663249
J Fam Plann Reprod Health Care. 2017 Oct;43(4):319-326. doi: 10.1136/jfprhc-2017-101740. Epub 2017 Jun 29.

INTRODUCTION: Unprotected intercourse after oral emergency contraception (EC) significantly increases pregnancy risk. This underlies the importance of promptly starting effective, ongoing contraception - known as 'quick starting'. However, theoretical concern exists that quick starting might interact with EC or...

Cite
Murphy LE, Chen ZE, Warner V, et al. Quick starting hormonal contraception after using oral emergency contraception: a systematic review. J Fam Plann Reprod Health Care. 2017;43(4):319-326doi: 10.1136/jfprhc-2017-101740.
Murphy, L. E., Chen, Z. E., Warner, V., & Cameron, S. T. (2017). Quick starting hormonal contraception after using oral emergency contraception: a systematic review. The journal of family planning and reproductive health care, 43(4), 319-326. https://doi.org/10.1136/jfprhc-2017-101740
Murphy, Lauren Ee, et al. "Quick starting hormonal contraception after using oral emergency contraception: a systematic review." The journal of family planning and reproductive health care vol. 43,4 (2017): 319-326. doi: https://doi.org/10.1136/jfprhc-2017-101740
Murphy LE, Chen ZE, Warner V, Cameron ST. Quick starting hormonal contraception after using oral emergency contraception: a systematic review. J Fam Plann Reprod Health Care. 2017 Oct;43(4):319-326. doi: 10.1136/jfprhc-2017-101740. Epub 2017 Jun 29. PMID: 28663249.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 455 entries